4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-25-005354
Director acquired 21,950 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sobel Alan D. Director | 2025-01-17 | Option exercise | +21,950 | $1.00 | $21,950 | 123,807 | D |
| Derivatives | |||||||
| Sobel Alan D. Director | 2025-01-17 | Option exercise · Subscription Rights (right to buy) | −21,950 | 0 | D | ||
| Sobel Alan D. Director | 2025-01-17 | Other acquisition · Series A Right Warrants | +21,950 | 21,950 | D | ||
| Sobel Alan D. Director | 2025-01-17 | Other acquisition · Series B Right Warrants | +21,950 | 21,950 | D | ||
Loading xslF345X05/tm254168-1_4seq1.xml…